Shockwave IVL peripheral

Manufacturer: Shockwave Medical

Category: Arterio-venous system devices

EMDN: C010402020699 - Peripheral atherectomy systems - other

Who sell it?

  • Shockwave Medical
device picture

No characteristic found

Key Features and USPs: Peripheral Intravascular Lithotripsy: - Like its coronary counterpart, the peripheral IVL system utilizes sonic pressure waves to fracture calcium deposits within the artery walls of the legs. This addresses a major challenge in PAD treatment.   - This application of lithotripsy in the peripheral vasculature allows for effective calcium modification in areas that have historically been very difficult to treat. Selective Calcium Modification: - IVL preferentially targets calcium, minimizing trauma to surrounding soft tissue. This is crucial in the peripheral arteries, where minimizing vessel injury is essential for long-term patency.   Enhanced Vessel Preparation: - By fracturing the calcium, IVL prepares the vessel for subsequent interventions, such as balloon angioplasty or stent placement. This leads to improved device delivery and expansion.   Reduced Complications: - Clinical studies have demonstrated that peripheral IVL is associated with a favorable safety profile, with lower rates of complications compared to traditional atherectomy methods. Versatility: - The system is designed to treat calcified lesions in various peripheral artery locations, including above and below the knee. This versatility makes it a valuable tool for a wide range of PAD patients. Ease of Use and Integration: - The peripheral IVL system integrates seamlessly into standard interventional procedures, simplifying adoption for physicians. Clinical Data: - The peripheral IVL system has robust clinical trials that demonstrate its safety, and efficacy in treating calcified lesions in the peripheral arteries.   In essence, Shockwave peripheral IVL offers a safe, effective, and minimally invasive approach to treating calcified PAD, improving vessel preparation and enhancing patient outcomes.